News IGM Biosciences, Inc.

Equities

IGMS

US4495851085

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
7.41 ^USD	-8.86%		-11.36%	-10.83%

Apr. 17	IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets	MT
Apr. 17	IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets	Apr. 17	MT
IGM Biosciences Announces Refocusing of Sanofi Collaboration	Apr. 17	GL
IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration	Apr. 17	CI
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum	Apr. 10	GL
North American Morning Briefing : Stocks Set for -2-	Mar. 28	DJ
HC Wainwright Adjusts IGM Biosciences Price Target to $12 From $7, Maintains Neutral Rating	Mar. 12	MT
Earnings Flash (IGMS) IGM BIOSCIENCES Reports Q4 Revenue $651,000	Mar. 07	MT
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Mar. 07	GL
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Mar. 07	AQ
IGM Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 07	CI
IGM Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2023	Feb. 15	AQ
North American Morning Briefing : Stock Futures -2-	Feb. 12	DJ
RBC Upgrades IGM Biosciences to Outperform From Sector Perform, Boosts Price Target to $21 From $9; Speculative Risk Kept	Feb. 09	MT
IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	Feb. 01	GL
IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	Feb. 01	AQ
Transcript : IGM Biosciences, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 11:15 AM	Jan. 10
IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	GL
North American Morning Briefing : Stock Futures -2-	Dec. 18	DJ
BofA Securities Downgrades IGM Biosciences to Neutral From Buy, Adjusts Price Target to $8 From $20	Dec. 15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News IGM Biosciences, Inc.

Equities

IGMS

US4495851085

Summary

Filters